BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 9553995)

  • 1. Comparison of prolactin concentrations between haloperidol and bromperidol treatments in schizophrenic patients.
    Yasui-Furukori N; Kondo T; Suzuki A; Mihara K; Kaneko S; Otani K
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):575-8. PubMed ID: 11999910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between carbamazepine and bromperidol.
    Otani K; Ishida M; Yasui N; Kondo T; Mihara K; Suzuki A; Furukori H; Kaneko S; Inoue Y
    Eur J Clin Pharmacol; 1997; 52(3):219-22. PubMed ID: 9218929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between steady-state plasma concentrations (Css) of bromperidol and haloperidol.
    Yasui N; Otani K; Kondo T; Suzuki A; Furukori H; Kaneko S; Inoue Y
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Apr; 22(3):485-92. PubMed ID: 9612845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma concentrations of bromperidol and its reduced metabolite with levomepromazine, but not with thioridazine.
    Suzuki A; Otani K; Ishida M; Yasui N; Kondo T; Mihara K; Kaneko S; Inoue Y; Shibata M; Ikeda K
    Ther Drug Monit; 1997 Jun; 19(3):261-4. PubMed ID: 9200764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol.
    Mihara K; Suzuki A; Kondo T; Yasui-Furukori N; Ono S; Otani K; Kaneko S; Inoue Y
    Am J Med Genet; 2001 Apr; 105(3):271-4. PubMed ID: 11353448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromperidol decanoate (depot) for schizophrenia.
    Purgato M; Adams CE
    Cochrane Database Syst Rev; 2011 Sep; (9):CD001719. PubMed ID: 21901678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromperidol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in psychoses.
    Benfield P; Ward A; Clark BG; Jue SG
    Drugs; 1988 Jun; 35(6):670-84. PubMed ID: 3048975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the clinical relevance and methods of quantification of plasma concentrations of neuroleptics.
    Ko GN; Korpi ER; Linnoila M
    J Clin Psychopharmacol; 1985 Oct; 5(5):253-62. PubMed ID: 2864357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin response to bromperidol treatment in schizophrenic patients.
    Yasui N; Kondo T; Otani K; Ishida M; Mihara K; Suzuki A; Kaneko S; Inoue Y
    Pharmacol Toxicol; 1998 Mar; 82(3):153-6. PubMed ID: 9553995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depot bromperidol decanoate for schizophrenia.
    Wong D; Adams CE; David A; Quraishi SN
    Cochrane Database Syst Rev; 2004; (3):CD001719. PubMed ID: 15266450
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.